Literature DB >> 25559402

Expanding the phenotypic spectrum and variability of endocrine abnormalities associated with TUBB3 E410K syndrome.

Ravikumar Balasubramanian1, Sheena Chew, Sarah E MacKinnon, Peter B Kang, Caroline Andrews, Wai-Man Chan, Elizabeth C Engle.   

Abstract

CONTEXT: A heterozygous de novo c.1228G>A mutation (E410K) in the TUBB3 gene encoding the neuronal-specific β-tubulin isotype 3 (TUBB3) causes the TUBB3 E410K syndrome characterized by congenital fibrosis of the extraocular muscles (CFEOM), facial weakness, intellectual and social disabilities, and Kallmann syndrome (anosmia with hypogonadotropic hypogonadism). All TUBB3 E410K subjects reported to date are sporadic cases.
OBJECTIVE: This study aimed to report the clinical, genetic, and molecular features of a familial presentation of the TUBB3 E410K syndrome.
DESIGN: Case report of a mother and three affected children with clinical features of the TUBB3 E410K syndrome.
SETTING: Academic Medical Center. MAIN OUTCOME MEASURES: Genetic analysis of the TUBB3 gene and clinical evaluation of endocrine and nonendocrine phenotypes.
RESULTS: A de novo TUBB3 c.1228G>A mutation arose in a female proband who displayed CFEOM, facial weakness, intellectual and social disabilities, and anosmia. However, she underwent normal sexual development at puberty and had three spontaneous pregnancies with subsequent autosomal-dominant inheritance of the mutation by her three boys. All sons displayed nonendocrine features of the TUBB3 E410K syndrome similar to their mother but, in addition, had variable features suggestive of additional endocrine abnormalities.
CONCLUSIONS: This first report of an autosomal-dominant inheritance of the TUBB3 c.1228G>A mutation in a family provides new insights into the spectrum and variability of endocrine phenotypes associated with the TUBB3 E410K syndrome. These observations emphasize the need for appropriate clinical evaluation and complicate genetic counseling of patients and families with this syndrome.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25559402      PMCID: PMC4333039          DOI: 10.1210/jc.2014-4107

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.

Authors:  Taneli Raivio; Magdalena Avbelj; Mark J McCabe; Christopher J Romero; Andrew A Dwyer; Johanna Tommiska; Gerasimos P Sykiotis; Louise C Gregory; Daniel Diaczok; Vaitsa Tziaferi; Mariet W Elting; Raja Padidela; Lacey Plummer; Cecilia Martin; Bihua Feng; Chengkang Zhang; Qun-Yong Zhou; Huaibin Chen; Moosa Mohammadi; Richard Quinton; Yisrael Sidis; Sally Radovick; Mehul T Dattani; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

2.  PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption.

Authors:  Rachel Reynaud; Sujatha A Jayakody; Carine Monnier; Alexandru Saveanu; Jérome Bouligand; Anne-Marie Guedj; Gilbert Simonin; Pierre Lecomte; Anne Barlier; Philippe Rondard; Juan Pedro Martinez-Barbera; Anne Guiochon-Mantel; Thierry Brue
Journal:  J Clin Endocrinol Metab       Date:  2012-03-30       Impact factor: 5.958

3.  Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.

Authors:  Nelly Pitteloud; Astrid Meysing; Richard Quinton; James S Acierno; Andrew A Dwyer; Lacey Plummer; Eric Fliers; Paul Boepple; Frances Hayes; Stephanie Seminara; Viriginia A Hughes; Jinghong Ma; Pierre Bouloux; Moosa Mohammadi; William F Crowley
Journal:  Mol Cell Endocrinol       Date:  2006-06-09       Impact factor: 4.102

Review 4.  Human GnRH deficiency: a unique disease model to unravel the ontogeny of GnRH neurons.

Authors:  Ravikumar Balasubramanian; Andrew Dwyer; Stephanie B Seminara; Nelly Pitteloud; Ursula B Kaiser; William F Crowley
Journal:  Neuroendocrinology       Date:  2010-07-07       Impact factor: 4.914

5.  Oligogenic basis of isolated gonadotropin-releasing hormone deficiency.

Authors:  Gerasimos P Sykiotis; Lacey Plummer; Virginia A Hughes; Margaret Au; Sadia Durrani; Sadhana Nayak-Young; Andrew A Dwyer; Richard Quinton; Janet E Hall; James F Gusella; Stephanie B Seminara; William F Crowley; Nelly Pitteloud
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

6.  Reversal of idiopathic hypogonadotropic hypogonadism.

Authors:  Taneli Raivio; John Falardeau; Andrew Dwyer; Richard Quinton; Frances J Hayes; Virginia A Hughes; Lindsay W Cole; Simon H Pearce; Hang Lee; Paul Boepple; William F Crowley; Nelly Pitteloud
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

7.  Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system.

Authors:  Valerie F Sidhoum; Yee-Ming Chan; Margaret F Lippincott; Ravikumar Balasubramanian; Richard Quinton; Lacey Plummer; Andrew Dwyer; Nelly Pitteloud; Frances J Hayes; Janet E Hall; Kathryn A Martin; Paul A Boepple; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

8.  University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic.

Authors:  R L Doty; P Shaman; C P Kimmelman; M S Dann
Journal:  Laryngoscope       Date:  1984-02       Impact factor: 3.325

9.  Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice.

Authors:  John Falardeau; Wilson C J Chung; Andrew Beenken; Taneli Raivio; Lacey Plummer; Yisrael Sidis; Elka E Jacobson-Dickman; Anna V Eliseenkova; Jinghong Ma; Andrew Dwyer; Richard Quinton; Sandra Na; Janet E Hall; Celine Huot; Natalie Alois; Simon H S Pearce; Lindsay W Cole; Virginia Hughes; Moosa Mohammadi; Pei Tsai; Nelly Pitteloud
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

10.  Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.

Authors:  Lindsay W Cole; Yisrael Sidis; ChengKang Zhang; Richard Quinton; Lacey Plummer; Duarte Pignatelli; Virginia A Hughes; Andrew A Dwyer; Taneli Raivio; Frances J Hayes; Stephanie B Seminara; Celine Huot; Nathalie Alos; Phyllis Speiser; Akira Takeshita; Guy Van Vliet; Simon Pearce; William F Crowley; Qun-Yong Zhou; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2008-06-17       Impact factor: 5.958

View more
  5 in total

Review 1.  Discovering Genes Essential to the Hypothalamic Regulation of Human Reproduction Using a Human Disease Model: Adjusting to Life in the "-Omics" Era.

Authors:  M I Stamou; K H Cox; William F Crowley
Journal:  Endocr Rev       Date:  2015-09-22       Impact factor: 19.871

Review 2.  Discovering Genes Essential to the Hypothalamic Regulation of Human Reproduction Using a Human Disease Model: Adjusting to Life in the "-Omics" Era.

Authors:  M I Stamou; K H Cox; William F Crowley
Journal:  Endocr Rev       Date:  2016-02       Impact factor: 19.871

Review 3.  Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease.

Authors:  Richard Quinton; Marco Bonomi; Biagio Cangiano; Du Soon Swee
Journal:  Hum Genet       Date:  2020-03-21       Impact factor: 4.132

4.  Diagnostic Application of Targeted Next-Generation Sequencing of 80 Genes Associated with Disorders of Sexual Development.

Authors:  Yanjie Fan; Xia Zhang; Lili Wang; Ruifang Wang; Zhuo Huang; Yu Sun; Ruen Yao; Xiaodong Huang; Jun Ye; Lianshu Han; Wenjuan Qiu; Huiwen Zhang; Lili Liang; Xuefan Gu; Yongguo Yu
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

5.  Optic Nerve Head and Retinal Abnormalities Associated with Congenital Fibrosis of the Extraocular Muscles.

Authors:  Mervyn G Thomas; Gail D E Maconachie; Helen J Kuht; Wai-Man Chan; Viral Sheth; Michael Hisaund; Rebecca J McLean; Brenda Barry; Bashir Al-Diri; Frank A Proudlock; Zhanhan Tu; Elizabeth C Engle; Irene Gottlob
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.